Literature DB >> 24281896

Monounsaturated 14:1n-9 and 16:1n-9 fatty acids but not 18:1n-9 induce apoptosis and necrosis in murine HL-1 cardiomyocytes.

Lars Hoffmann1, Annette Seibt, Diran Herebian, Ute Spiekerkoetter.   

Abstract

Patients with inborn errors of long-chain fatty acid oxidation accumulate disease-specific acylcarnitines and triacylglycerols in various tissues. Some of these patients present significant cardiac diseases such as arrhythmias and cardiomyopathy. The mechanism of how fatty acid accumulation is involved in disease pathogenesis is still unclear but apoptosis of cardiomyocytes has been suggested to be one possible mechanism of cardiomyopathy development. In this study, we measured lipid uptake and intracellular lipid accumulation after incubation of HL1 cardiomyocytes with different saturated and monounsaturated long- and medium-chain fatty acid species for various time periods and at different physiological concentrations. We assessed apoptosis induction by analyzing the mitochondrial membrane potential and TLR-4 expression as well as the composition of the accumulating triacylglycerols. We identified only 14:1 and 16:1 monounsaturated fatty acids potentially leading to an increase in TLR-4 expression and disruption of the mitochondrial membrane potential, resulting in apoptosis and necrosis in cultured cardiomyocytes. This study demonstrates significant toxicity of especially those fatty acid species in vitro that significantly accumulate in fatty acid oxidation defects presenting with cardiac disease such as very long-chain acyl-CoA dehydrogenase, carnitine acylcarnitine translocase and carnitine palmitoyl-CoA transferase deficiencies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24281896     DOI: 10.1007/s11745-013-3865-4

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  30 in total

1.  Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4.

Authors:  J Y Lee; K H Sohn; S H Rhee; D Hwang
Journal:  J Biol Chem       Date:  2001-03-02       Impact factor: 5.157

Review 2.  Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.

Authors:  Helena Erlandsson Harris; Ulf Andersson
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

3.  CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis.

Authors:  Sophie C Cazanave; Nafisa A Elmi; Yuko Akazawa; Steven F Bronk; Justin L Mott; Gregory J Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

4.  HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte.

Authors:  W C Claycomb; N A Lanson; B S Stallworth; D B Egeland; J B Delcarpio; A Bahinski; N J Izzo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

5.  Osmotic regulation of betaine homocysteine-S-methyltransferase expression in H4IIE rat hepatoma cells.

Authors:  Christine Schäfer; Lars Hoffmann; Katrin Heldt; Mohammad Reza Lornejad-Schäfer; Gernot Brauers; Thor Gehrmann; Timothy A Garrow; Dieter Häussinger; Ertan Mayatepek; Bernd C Schwahn; Freimut Schliess
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-01-11       Impact factor: 4.052

6.  Cell death, caspase activation, and HMGB1 release of porcine choroid plexus epithelial cells during Streptococcus suis infection in vitro.

Authors:  Tobias Tenenbaum; Frank Essmann; Rüdiger Adam; Annette Seibt; Reiner U Jänicke; Gerd E K Novotny; Hans-Joachim Galla; Horst Schroten
Journal:  Brain Res       Date:  2006-06-15       Impact factor: 3.252

7.  A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.

Authors:  Renata Belfort; Stephen A Harrison; Kenneth Brown; Celia Darland; Joan Finch; Jean Hardies; Bogdan Balas; Amalia Gastaldelli; Fermin Tio; Joseph Pulcini; Rachele Berria; Jennie Z Ma; Sunil Dwivedi; Russell Havranek; Chris Fincke; Ralph DeFronzo; George A Bannayan; Steven Schenker; Kenneth Cusi
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

8.  Unbound free fatty acid levels in human serum.

Authors:  G V Richieri; A M Kleinfeld
Journal:  J Lipid Res       Date:  1995-02       Impact factor: 5.922

9.  Programmed cell death induced by ceramide.

Authors:  L M Obeid; C M Linardic; L A Karolak; Y A Hannun
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

Review 10.  The PPAR trio: regulators of myocardial energy metabolism in health and disease.

Authors:  Jose A Madrazo; Daniel P Kelly
Journal:  J Mol Cell Cardiol       Date:  2008-04-04       Impact factor: 5.000

View more
  8 in total

1.  Increased and early lipolysis in children with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency during fast.

Authors:  C Bieneck Haglind; A Nordenström; S Ask; U von Döbeln; J Gustafsson; M Halldin Stenlid
Journal:  J Inherit Metab Dis       Date:  2014-08-21       Impact factor: 4.982

Review 2.  Carnitine transport and fatty acid oxidation.

Authors:  Nicola Longo; Marta Frigeni; Marzia Pasquali
Journal:  Biochim Biophys Acta       Date:  2016-01-29

3.  Advances in the Understanding and Treatment of Mitochondrial Fatty Acid Oxidation Disorders.

Authors:  Eric S Goetzman
Journal:  Curr Genet Med Rep       Date:  2017-07-25

Review 4.  Evidence that Oxidative Disbalance and Mitochondrial Dysfunction are Involved in the Pathophysiology of Fatty Acid Oxidation Disorders.

Authors:  Graziela Schmitt Ribas; Carmen Regla Vargas
Journal:  Cell Mol Neurobiol       Date:  2020-09-02       Impact factor: 5.046

5.  Estimates of genomic heritability and genome-wide association study for fatty acids profile in Santa Inês sheep.

Authors:  G A Rovadoscki; S F N Pertile; A B Alvarenga; A S M Cesar; F Pértille; J Petrini; V Franzo; W V B Soares; G Morota; M L Spangler; L F B Pinto; G G P Carvalho; D P D Lanna; L L Coutinho; G B Mourão
Journal:  BMC Genomics       Date:  2018-05-21       Impact factor: 3.969

Review 6.  Recent Advances in the Pathophysiology of Fatty Acid Oxidation Defects: Secondary Alterations of Bioenergetics and Mitochondrial Calcium Homeostasis Caused by the Accumulating Fatty Acids.

Authors:  Alexandre Umpierrez Amaral; Moacir Wajner
Journal:  Front Genet       Date:  2020-11-27       Impact factor: 4.599

Review 7.  Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies.

Authors:  Moacir Wajner; Alexandre Umpierrez Amaral
Journal:  Biosci Rep       Date:  2015-11-20       Impact factor: 3.840

8.  Sirt3 modulates fatty acid oxidation and attenuates cisplatin-induced AKI in mice.

Authors:  Ming Li; Can-Ming Li; Zeng-Chun Ye; Jiayan Huang; Yin Li; Weiyan Lai; Hui Peng; Tan-Qi Lou
Journal:  J Cell Mol Med       Date:  2020-04-12       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.